Skip to content
Primary Menu
About
Management Team
Board of Directors
About NXP900
Publications
NXP800
NXP900
Clinical Trials
Careers
Investors
Contact
Presentations
Corporate Presentation (May 2026)
NXP900 Phase 1b KOL Event (December 2025)
Press Releases
SEC Filings
Events
Upcoming and Recent Events
H.C. Wainwright 4th Annual BioConnect Investor Conference
May 19th, 2026
Webcast Link
Past Events
Nuvectis KOL Event - NXP900 Phase 1B Program
December 2nd, 2025
Webcast Link
Stock Information
Governance
Corporate Governance Guidelines
Code of Business Conduct and Ethics
Audit Committee Charter
Compensation Committee Charter
Email Alerts
Sign up for email updates. Enter your email, choose the content of interest and click Subscribe.